+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma



CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma



Cancer Letters 235(1): 34-39



CD24, a cell surface protein originally identified in hematological malignancy, were found to be expressed in a large variety of solid tumors. It can function as a ligand for P-selectin, an adhesion receptor on activated endothelial cells and platelets. Overexpression of CD24 enhances the metastatic potential of cancer cells. We examined the expression of CD24 in 70 intrahepatic cholangiocarcinomas by immunohistochemistry and correlated the expression with clinicopathological parameters. CD24 was expressed in 36 of 70 (51%) intrahepatic cholangiocarcinomas. The expression did not significantly correlate the tumor size, stage, lymph node and distant metastasis. Patients with CD24 positive tumors had significant shorter survival time. In a multivariant analysis, CD24 expression and tumor stage were independent prognostic factors. Our data suggest that CD24 expression in intrahepatic cholangiocarcinoma is a novel prognostic marker for intrahepatic cholangiocarcinoma.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011821935

Download citation: RISBibTeXText

PMID: 16125303

DOI: 10.1016/j.canlet.2005.03.059


Related references

The associated expression of Maspin and Bax proteins as a potential prognostic factor in intrahepatic cholangiocarcinoma. Bmc Cancer 6: 255, 2006

Expression of matrix metalloproteinase-7 is an unfavorable prognostic factor in intrahepatic cholangiocarcinoma. Journal of Gastrointestinal Surgery 16(4): 842-848, 2012

CD44 Expression Is a Prognostic Factor in Patients with Intrahepatic Cholangiocarcinoma After Surgical Resection. Anticancer Research 37(10): 5701-5705, 2017

Elevated expression of cyclooxygenase-2 is a negative prognostic factor for overall survival in intrahepatic cholangiocarcinoma. Virchows Archiv 450(2): 135-141, 2007

Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma. Digestive and Liver Disease 37(4): 269-274, 2005

ERCC1 Can Be a Prognostic Factor in Hilar Cholangiocarcinoma and Extrahepatic Bile Duct Cancer, But Not in Intrahepatic Cholangiocarcinoma. Cancer Research and Treatment 45(1): 63-69, 2013

CD24 expression is an independent prognostic marker in cholangiocarcinoma. Journal of Gastrointestinal Surgery 11(4): 445-451, 2007

Inactivation of Smad4 is a prognostic factor in intrahepatic cholangiocarcinoma. Chinese Medical Journal 126(16): 3039-3043, 2013

Perineural invasion is a prognostic factor in intrahepatic cholangiocarcinoma. World Journal of Surgery 32(11): 2395-2402, 2008

Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma. Pathology Oncology Research 16(2): 169-175, 2010

Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinoma. International Journal of Clinical and Experimental Pathology 4(4): 363-370, 2011

MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type. Hepatology 39(1): 220-229, 2004

Is resection for solitary ≤5 cm intrahepatic cholangiocarcinoma an independent prognostic factor for survival?. Surgery 165(4): 853-858, 2019

Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma. Annals of Surgical Oncology 15(2): 583-589, 2008

Hepatoma-derived growth factor: a novel prognostic biomarker in intrahepatic cholangiocarcinoma. Tumour Biology 36(1): 353-364, 2015